Sanofi Research and Development Expenses 2010-2025 | SNY

Sanofi research and development expenses for the twelve months ending March 31, 2025 were $8.039B, a 7.62% increase year-over-year.

  • Sanofi annual research and development expenses for 2024 were $8.001B, a 9.88% increase from 2023.
  • Sanofi annual research and development expenses for 2023 were $7.282B, a 3.06% increase from 2022.
  • Sanofi annual research and development expenses for 2022 were $7.065B, a 4.92% increase from 2021.

Sanofi Research and Development Expenses 2010-2025 | SNY

  • Sanofi annual research and development expenses for 2024 were $8.001B, a 9.88% increase from 2023.
  • Sanofi annual research and development expenses for 2023 were $7.282B, a 3.06% increase from 2022.
  • Sanofi annual research and development expenses for 2022 were $7.065B, a 4.92% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$796.4B
Johnson & Johnson (JNJ)$379.5B
AbbVie (ABBV)$306B
Novo Nordisk (NVO)$260.6B
Roche Holding AG (RHHBY)$248.1B
Novartis AG (NVS)$234.2B
Merck (MRK)$196.7B
Pfizer (PFE)$125.6B
Bayer (BAYRY)$23.7B
Innoviva (INVA)$1.1B